Product Information
VENLAFAXINE HCL ER 37.5 MG CAP is a generic product labeled by Major Pharmaceuticals, priced at $0.0795 per EA under NDC 00904748761. Its NADAC has been published 32 times since Jan 14, 2026.
FDA first approved this application on Apr 14, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904748761
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200834FDA Approved
4/14/2011
TE Code
AB
On Market Since
10/8/2025
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has been published 32 times since Jan 14, 2026, and over the history we have for it it has declined 11.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0795 per EA |
|---|---|
| All-time high | $0.0909 (Feb 11, 2026) |
| All-time low | $0.0795 (Aug 19, 2026) |
| 52-week high | $0.0909 |
| 52-week low | $0.0795 |
| Median price | $0.0865 |
| Average price | $0.0864 |
| Largest weekly change | -3.8% (Jul 22, 2026) |
| Weeks tracked | 32 |
| Tracking since | Jan 14, 2026 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG CAP, manufactured by Major Pharmaceuticals, is $0.0795 per EA (NDC 00904748761), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL ER 37.5 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has declined 11.8%. It has been tracked across 32 weekly CMS publications since Jan 14, 2026.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG CAP?
Since Jan 14, 2026, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has ranged from a low of $0.0795 (Aug 19, 2026) to a high of $0.0909 (Feb 11, 2026), with a median of $0.0865 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG CAP?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 37.5 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 37.5 MG CAP?
VENLAFAXINE HCL ER 37.5 MG CAP (NDC 00904748761) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.